Literature DB >> 19194769

Treatment of T3 gallbladder cancer.

Menghua Dai1, Yuman Fong, Andrew Lowy.   

Abstract

Until recently, advanced stage gallbladder cancer has been viewed with great pessimism and many patients abandoned as without potentially curative treatment option. Recent results have significantly improved due to a number of advances. Improvements in radiologic staging including positron emission tomography now allow selection of patients with disease treatable by local regional resection. With improvements in surgical and anesthetic techniques, aggressive surgery has proven T3 and T4 tumors to be resectable with safety and result in long-term survival.

Entities:  

Mesh：

Year:  2009        PMID： 19194769     DOI： 10.1007/s11605-009-0810-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


  6 in total

1.  Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention.

Authors:  Y Fong; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

2.  18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.

Authors:  Carlos U Corvera; Leslie H Blumgart; Timothy Akhurst; Ronald P DeMatteo; Michael D'Angelica; Yuman Fong; William Robert Jarnagin
Journal:  J Am Coll Surg       Date:  2007-10-01       Impact factor: 6.113

3.  Gallbladder cancer discovered during laparoscopic surgery. Potential for iatrogenic tumor dissemination.

Authors:  Y Fong; M F Brennan; A Turnbull; D G Colt; L H Blumgart
Journal:  Arch Surg       Date:  1993-09

4.  Hepatectomy of segment 4a and 5 combined with extra-hepatic bile duct resection for T2 and T3 gallbladder carcinoma.

Authors:  Naohiko Kohya; Kohji Miyazaki
Journal:  J Surg Oncol       Date:  2008-05-01       Impact factor: 3.454

5.  Extended hepatic resection for gallbladder cancer.

Authors:  Srinevas K Reddy; Carlos E Marroquin; Paul C Kuo; Theodore N Pappas; Bryan M Clary
Journal:  Am J Surg       Date:  2007-09       Impact factor: 2.565

6.  Surgery for gallbladder cancer: a population-based analysis.

Authors:  Natalie G Coburn; Sean P Cleary; Jensen C C Tan; Calvin H L Law
Journal:  J Am Coll Surg       Date:  2008-05-12       Impact factor: 6.113
  6 in total
  4 in total

1.  Adjuvant Therapy for Gallbladder Cancer: an Analysis of the National Cancer Data Base.

Authors:  Richard S Hoehn; Koffi Wima; Audrey E Ertel; Alexandra Meier; Syed A Ahmad; Shimul A Shah; Daniel E Abbott
Journal:  J Gastrointest Surg       Date:  2015-08-21       Impact factor: 3.452

2.  The prognostic impact of positive lymph nodes in stages T1 to T3 incidental gallbladder carcinoma: results of the German Registry.

Authors:  Thorsten Oliver Goetze; Vittorio Paolucci
Journal:  Surg Endosc       Date:  2011-11-17       Impact factor: 4.584

3.  Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer.

Authors:  Jean M Butte; T Peter Kingham; Mithat Gönen; Michael I D'Angelica; Peter J Allen; Yuman Fong; Ronald P DeMatteo; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2014-05-16       Impact factor: 6.113

4.  Practical guidelines for the surgical treatment of gallbladder cancer.

Authors:  Seung Eun Lee; Kyung Sik Kim; Wan Bae Kim; In-Gyu Kim; Yang Won Nah; Dong Hee Ryu; Joon Seong Park; Myung Hee Yoon; Jai Young Cho; Tae Ho Hong; Dae Wook Hwang; Dong Wook Choi
Journal:  J Korean Med Sci       Date:  2014-10-08       Impact factor: 2.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.